Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Randomized, Double Blind, Placebo-Controlled Clinical Trial to Investigate the Anti-oxidant Activity of Heptex in Patients With Apparent Risk Factors of Nonalcoholic Steatohepatitis (NASH)

NCT05343780 is registered in ClinicalTrials.gov with Natural Wellness Egypt as lead sponsor.

NCT NCT05343780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05343780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Randomized, Double Blind, Placebo-Controlled Clinical Trial to Investigate the Anti-oxidant Activity of Heptex in Patients With Apparent Risk Factors of Nonalcoholic Steatohepatitis (NASH)
Lead sponsor
Natural Wellness Egypt
Phase
Phase 2
Overall status
Completed
Start date
May 8, 2019
Completion date
February 21, 2022
Enrollment
142 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

nonalcoholic steatohepatitis